Marianna B. Ruzinova, Yi-Shan Lee, Eric J. Duncavage, John S. Welch. TP53 immunohistochemistry correlates with TP53 mutation status and clearance in decitabine-treated patients with myeloid malignancies. Haematologica 2019;104(8):e345-e348; https://doi.org/10.3324/haematol.2018.205302.